Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 214523
Company: PRECISION DOSE INC
Company: PRECISION DOSE INC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | EQ 70MG BASE/75ML | SOLUTION;ORAL | Prescription | AA | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 09/02/2026 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/214523Orig1s000ltr.pdf |
ALENDRONATE SODIUM
SOLUTION;ORAL; EQ 70MG BASE/75ML
TE Code = AA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | EQ 70MG BASE/75ML | SOLUTION;ORAL | Prescription | No | AA | 090520 | HIKMA |
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | EQ 70MG BASE/75ML | SOLUTION;ORAL | Prescription | No | AA | 214512 | NOVITIUM PHARMA |
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | EQ 70MG BASE/75ML | SOLUTION;ORAL | Prescription | No | AA | 214523 | PRECISION DOSE INC |